Toll-like receptor (TLR)-mediated innate immune responses are important in early host defense. Using a candidate gene approach, we previously identified genetic variation within TLR1 that is associated with hyper-responsiveness to a TLR1/2 agonist in vitro and with death and organ dysfunction in patients with sepsis. Here we report a genome-wide association study (GWAS) designed to identify genetic loci controlling whole blood cytokine responses to the TLR1/2 lipopeptide agonist, Pam 3 CSK 4 (N-palmitoyl-Sdipalmitoylglyceryl Cys-Ser-(Lys) 4 ) ex vivo. We identified a very strong association (Po1 Â 10 À 27 ) between genetic variation within the TLR10/1/6 locus on chromosome 4, and Pam 3 CSK 4 -induced cytokine responses. This was the predominant association explaining over 35% of the population variance for this phenotype. Notably, strong associations were observed within TLR10, suggesting that genetic variation in TLR10 may influence bacterial lipoprotein-induced responses. These findings establish the TLR10/1/6 locus as the dominant common genetic factor controlling interindividual variability in Pam 3 CSK 4 -induced whole blood responses in the healthy population.
INTRODUCTION
The innate immune system provides early recognition of microbial pathogens important to host defense. Toll-like receptors (TLRs) play a key role in host defense, providing a mechanism to respond to highly conserved pathogen-associated molecular patterns. 1 In humans, there are 10 unique TLR genes coding for receptors that initiate responses to pathogen-associated molecular pattern ligands with a robust inflammatory response. TLR2 heterodimerizes with TLR6, TLR1 and possibly TLR10, and these combinations facilitate the recognition of multiple distinct bacterial patterns diversifying innate immune sensing. [2] [3] [4] The importance of TLR2 in host defense has been well established in mice where its deficiency has been associated with increased susceptibility to mycobacterial infection, pneumococcal meningitis and sepsis due to Staphylococcus aureus and Listeria monocytogenes. [5] [6] [7] [8] TLR1/2 and TLR2/6 heterodimers can discriminate the acylation of bacterial lipopeptides recognizing triacyl-and diacyllipopeptides, respectively. 2, [9] [10] [11] The synthetic triacyl lipopeptide N-palmitoyl-S-dipalmitoylglyceryl Cys-Ser-(Lys) 4 (Pam 3 CSK 4 ) and diacyl lipopeptide fibroblast stimulating ligand-1 (FSL-1) derived from Mycoplasma salivarium have been shown to stimulate via TLR1/2 and TLR2/6 heterodimers. 2, 12 Additionally, TLR2/6 heterodimers recognize peptidoglycan (PGN) and a yeast cell wall particle, Zymosan. 13, 14 A role for TLR1/2 and TLR2/6 in human disease has been suggested by candidate gene studies. We and others have demonstrated that there exists high interindividual variability in terms of human leukocyte inflammatory responses to pathogen-associated molecular patterns, 15, 16 and that a portion of this variability is attributable to common genetic variants. Genetic variation in TLR2 has been shown to confer reduced responses to PGN and heat-killed S. aureus in vitro. 17 More recently, we have demonstrated that variants in TLR1 are highly associated with Pam 3 CSK 4 -induced whole blood cytokine production. We reported that common genetic variants in TLR1 conferred marked hyperresponsiveness to Pam 3 CSK 4 and these same variants were associated with increased risk of organ dysfunction and death in septic shock. 15, 18 Other studies have demonstrated associations between genetic variation in TLR1 with susceptibility to leprosy and tuberculosis. 19, 20 These data support a role for TLR1/2-mediated responses in human disease. However, to date, our understanding of the role for genetic variation in TLR-mediated responses has been based on targeted candidate gene studies. Thus, in order to more comprehensively assess the genetic factors controlling TLR2-mediated responses in the healthy human population, we undertook a genome-wide association study (GWAS) to identify loci modifying Pam 3 CSK 4 -induced cytokine production in whole blood ex vivo.
RESULTS
We employed samples from 360 healthy Caucasian subjects who had an average age of 35 ± 14 years and were 39% male. Given that many innate immunity genes demonstrate population differences in allele frequencies including the genes coding for TLRs, 21 we performed principal component analysis (PCA) to address the possibility that there might exist population admixture within our genotyped subjects. PCA revealed that subjects who self-reported as Caucasian cluster with Caucasians from Utah (CEU) and the Toscani in Italia (TSI) populations from the HapMap3 collection 22 (Supplementary Figure S1) . However, we did identify associations between eigenvalues from the first three principal components and TLR agonist-induced cytokine production and hence these eigenvalues were used as covariates in the multiple linear regression models for the GWAS.
We used a genome-wide association test adjusted for age, gender and the first three principal components, and identified 19 single-nucleotide polymorphisms (SNPs) within the TLR10/1/6 locus on chromosome 4 that were associated with Pam 3 CSK 4 -induced interleukin (IL)-6 (Figure 1a) , IL-1b and tumor necrosis factor-a production in whole blood (Supplementary Figure S2 ) at a genome-wide level of significance (P ¼ 1 Â 10 À 8 -P ¼ 1 Â 10 À 27 ; Table 1 ). No other loci achieved associations at a genome-wide level of significance including SNPs found in genes involved in TLR1/2 signaling such as TIRAP, IRAK4 and IRAK1 that we had anticipated a priori to be associated with the cytokine-induced phenotypes (Table 2) . Notably, all cytokine values obtained from the whole blood assay were normalized to a monocyte count obtained from the donor at the time of phlebotomy. In this way we mitigated the chances of identifying variation that merely affected the number of circulating monocytes.
We next sought to identify loci associated with responses to TLR2/6 ligands FSL-1, PGN and Zymosan in 167 subjects for whom we had measured whole blood responses to these ligands. We did not identify any associations reaching genome-wide significance ( Figure 1b ) and, notably, no SNPs within the TLR10/1/6 locus or TLR2 were even nominally associated (P40.05) with responses to these ligands. Nonetheless, there were several moderately strong associations detected at other genomic loci with these cytokine responses ranging from P ¼ 1.55 Â 10 À 6 (Zymosan-induced IL-6), P ¼ 3.30 Â 10 À 6 (FSL-induced IL-6) to P ¼ 4.37 Â 10 À 6 (PGNinduced IL-6). As these analyses included fewer subjects than the GWAS of Pam 3 CSK 4 -induced responses, we re-ran the GWAS of Pam 3 CSK 4 -induced IL-6 using only these 167 subjects. This analysis still identified multiple SNPs that were associated at a genomewide level of significance (Po4. Interindividual difference in TLR1/2-mediated responses C Mikacenic et al orders of magnitude stronger than any associations with TLR2/6 agonist-induced responses.
In order to identify SNPs within the TLR10/1/6 locus not directly genotyped by our platform that may be driving the observed associations with Pam 3 CSK 4 -induced cytokine production, we used imputation to infer missing genotypes on chromosome 4 using 1000 genomes NCBI Build 37 23 as a reference population. These imputed SNPs were tested for association with the Pam 3 CSK 4 -induced cytokine phenotypes. We observed a 222-kb region across the TLR10/1/6 locus that was associated with Pam 3 CSK 4 -induced IL-6 at a genome-wide level of significance ( Figure 2 ). The SNP most highly associated with hypermorphic responses was rs67719080 (P ¼ 1 Â 10 À 27 ), an intergenic SNP between TLR10 and TLR1. Of the SNPs that fell within genes, SNPs within TLR10 were most highly associated with hypermorphic cytokine responses (Figure 2 ). The most highly associated TLR10 coding SNP was rs4129009 (TLR10 2323A/G ), a nonsynonymous polymorphism that causes an amino acid change in the highly conserved Toll/Interleukin-1 receptor (TIR) domain. Individuals homozygous for the rare allele had increased IL-6 production consistent with a hypermorphic response (Figure 3 ). In addition to the TIR domain SNP, we also identified a missense SNP in TLR10, rs11096955 (I369L), near leucine-rich repeat 9 (LRR9: amino acids 349-368) of TLR10 that was strongly associated with hypermorphic responses to Pam 3 CSK 4 (P ¼ 5.36 Â 10 À 16 ). Coding SNPs within TLR1 were also highly associated with the Pam 3 CSK 4 -induced cytokine phenotype including rs4833095 (TLR1 742A/G ) and rs5743618 (TLR1 1805G/T ) but were not in high linkage disequilibrium with the TLR10 coding SNP rs4129009 (Table 3) , suggesting a distinct association. Notably, rs5743551, a SNP found 5 0 to TLR1 that we have previously shown to be highly associated with death and organ dysfunction in sepsis, was also highly associated (P ¼ 2.8 Â 10 À 24 ). Finally, we also found a strong association with a nonsynonymous variant in TLR6 (rs5743818, ). This SNP was not found to be in high linkage disequilibrium with the other most highly associated coding SNPs in TLR1 (R 2 ¼ 0.11) and TLR10 (R 2 ¼ 0.08) ( Table 3) . Interindividual difference in TLR1/2-mediated responses C Mikacenic et al
DISCUSSION
In this GWAS, we found that the TLR10/1/6 region on chromosome 4 is the dominant common genetic locus controlling interindividual variation in responses to Pam 3 CSK 4 in whole blood from healthy subjects ex vivo. Although the genes coding for TLRs are distributed throughout the genome, TLR10, TLR1 and TLR6 cluster at a locus on chromosome 4p14. Evidence suggests that this tandem arrangement arose from a gene duplication event. 24 Notably, all three of these genes have significant allelic heterogeneity with an abundance of rare variants that may indicate an influence of purifying selection. 24 In addition, there exist significant geographic differences in genetic variation between European populations within the TLR10/1/6 locus. 21 However, our PCA shows that our subjects clustered with Caucasian populations in HapMap3 and our adjustment with principal components in the linear regression suggests that the association testing is not confounded by cryptic population substructure.
Among the SNPs within TLR1 showing the strongest associations in our study were several that have been previously associated with susceptibility to leprosy (rs5743618), 25 risk for prostate cancer and placental malaria (rs4833095). 26, 27 These findings are consistent with the assertion that functional responses mediated by TLR1/2 heterodimers might drive important biologic responses and alter risk for disease. We were more surprised to find strong associations with coding SNPs within TLR10 as there is no known ligand specific for TLR10 and it is not known that TLR10 ligation actually generates an intracellular response. 4, 28 These findings suggest that SNPs within TLR10 may contribute to associations between disease susceptibility and the TLR10/1/6 locus. The most highly associated nonsynonymous SNP in TLR10, rs4129009, causes an amino-acid change in the TIR domain of the intracellular portion of the protein. The TIR domain is critical for intracellular signaling in other TLR family members. 29, 30 A recent study has shown that a chimeric receptor containing the extracellular domain of TLR10 and the intracellular domain of TLR1 (including the TIR domain) induced a cellular response to Pam 3 CSK 4 comparable to wild-type TLR1. 4 This study suggests that the extracellular portion of TLR10 recognizes Pam 3 CSK 4 but that the intracellular portion of TLR10 does not translate this recognition event to an intracellular signal. Our study shows that individuals homozygous for the rare allele of rs4129009 in TLR10 have increased cytokine responses, suggesting that this genetic alteration of the TIR domain may result in a functionally active TLR10 molecule. Of note, this SNP has previously been reported to be associated with decreased risk of atopic asthma. 31 In addition to this SNP in the TIR domain, we identified another highly associated missense SNP in TLR10, rs11096955 (I369L), near LRR9, that could alter ligand binding. In order to best identify whether the TLR10 signal is an independent association, future research should be aimed at other racial groups where haplotype blocks in these region are smaller. Future work will need to more finely delineate whether SNPs in TLR10 or TLR1 (or both) are causally responsible for the associations observed. However, because of moderate linkage disequilibrium, conditional regression analysis adjusting for the top SNPs in this analysis was underpowered to detect independent associations.
The importance of genetic variation in TLR genes and downstream TLR signaling genes is highlighted by candidate gene studies that have demonstrated associations between variants in these genes and diseases for which host defense and inflammation is pathologic. With respect to genes encoding the TLR1/2 heterodimer, functional polymorphisms within the TLR10/1/6 locus and TLR2 have been associated with altered susceptibility to the mycobacterial infections of leprosy and tuberculosis. 19, 20, 32 A TLR1 polymorphism (rs5743618, Ser602Ile) that mediates higher levels of signaling and cell surface expression 15, 19 is associated with protection from recurrent urinary tract infection and pyelonephritis. 33 In sepsis, where severe infection leads to overwhelming inflammation and end-organ dysfunction, a TLR1 polymorphism (rs5743551) associated with marked hyperresponsiveness has been associated with the risk of death and organ dysfunction and sepsis-induced acute lung injury. 15, 18 Outside of infectious diseases, polymorphisms within the TLR10/ 1/6 locus have been variably associated with prostate cancer, non-Hodgkin's lymphoma, Crohn's disease, asthma and chronic sarcoidosis. 26, 31, [34] [35] [36] [37] [38] [39] [40] Our findings that the TLR10/1/6 locus explains a large portion of population variance in TLR1/2-mediated responses in vitro provides additional support for the importance of this locus in human disease.
Several previous reports have demonstrated associations between disease risk and genetic variation in TLRs and genes of the TLR intracellular signaling pathway including TLR2, TIRAP, IRAK4 and IRAK1. [41] [42] [43] In spite of these previous findings, we detected only a nominally significant association with variants in some TLR-related genes ( Table 2 ). It should be noted that this study was designed to have adequate statistical power to detect associations with common genetic factors (minor allele frequency 45%). This study is inadequately powered for detection of associations with rare genetic variants (minor allele frequency o1%) and, therefore, we cannot exclude the possibility that rare variants within these or other genes may also play a role in modulating these effects. Nonetheless, our findings suggest that common genetic variation in TLR pathway genes outside of the TLR10/1/6 locus play only a minor role in modifying TLR1/2 responses in the Caucasian population.
In summary, our study shows that genetic variation within the TLR10/1/6 locus is the major common genetic factor explaining interindividual variation in TLR1/2-mediated cytokine responses to Pam 3 CSK 4 in vitro. We find that the mostly highly associated SNPs fall within TLR10 and that some of these SNPs are located in or near important functional domains (TIR domain and LRR9) of TLR10, suggesting that this receptor might have functional relevance. Overall, this study supports ongoing efforts to understand the importance of this locus to human diseases involving innate immunity.
MATERIALS AND METHODS

Study subjects
We used DNA samples and innate immune response phenotypes collected from 360 healthy Caucasian volunteers recruited from the Seattle metropolitan area from whom written informed consent was obtained. This was approved by the University of Washington Human Subjects Committee. This population has been previously described by our group. 15 Cytokine assays Innate immune responses were measured in whole blood ex vivo as previously described. 16 Whole blood collected from each subject was exposed to Pam 3 CSK 4 (360 subjects at 100 ng ml À 1 ), FSL-1, PGN (167 subjects at 100 ng ml À 1 ) and Zymosan (179 subjects at 100 mg ml À 1 ) for 6 h, supernatants were collected and production of tumor necrosis factor-a, IL-1b, IL-6, IL-8, IL-10, granulocyte colony-stimulating factor), IL-1 receptor antagonist and monocyte-chemotactic protein-1 was measured by cytometric bead-based immunoassay (Luminex, Austin, TX, USA). A complete blood count with differential cell counts was obtained at the time of blood sampling for the stimulation assays and cytokine concentrations were normalized to monocyte counts.
Genotyping and imputation
Genomic DNA was genotyped using the Illumina (San Diego, CA, USA) Human 1M Beadchip array. In addition, we imputed genotypes on chromosome 4 not present on the array with the BEAGLE software package version 3.3 44 using EUR genotypes from 1000 Genomes 23 as a reference.
Quality control
Quality control was performed as described by Anderson et al. 45 We assessed for discordance between reported sex and genotype-determined sex, excess autosomal heterozygosity, excess relatedness (identity by descent of 40.1875) and population substructure using PCA and removed 14 subjects, resulting in a total of 346 subjects. All subjects had a genotype call rate of over 97%. The 561 491 SNPs were filtered to remove all SNPs with a minor allele frequency o0.05, Hardy-Weinberg equilibrium Po0.001 or a call rate p0.90, resulting in 493 197 SNPs that were used for association testing. Imputed SNPs for chromosome 4 were filtered for an allelic R 2 of 0.85.
Data analysis
We tested for associations between genome-wide genotypes and log 10 -transformed, monocyte-normalized, cytokine values by multiple linear regression assuming additive effects. Subjects and SNPs passing quality control filtering were tested for association with Pam 3 CSK 4 -induced, monocyte-normalized, whole blood cytokine production, adjusting for covariates including age, gender and eigenvalues from the first three principal components generated by PCA clustering subjects with samples from HapMap3 (Release 3, NCBI build 36). 22 Correcting for multiple tests, we considered a Po1 Â 10 À 8 to be indicative of genome-wide significance. We assigned P-values to TLR signaling genes anticipated a priori to be associated with the cytokine phenotype by choosing the P-value of the highest SNP within a 50-kb range from the 5 0 and 3 0 end of the gene. All above analyses were performed and linkage disequilibrium calculated using the Golden Helix (Bozeman, MT, USA) software package.
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